September 24th，Tasses (600535) Announcement，It will invest 151 million to acquire 45%equity of Henan Tiandi Pharmaceutical Co., Ltd.，Introduction to Wake -up Brain Remaining Fitting through the Holding Tiandi Pharmaceutical，rich and supplementing the product type of the My stake betting appStake Sports Bettingproduct line of the company's cardiovascular and cerebrovascular drugs。
Tiandi Pharmaceutical's predecessor was founded in Kaifeng Chinese Medicine Pharmaceutical Factory in 1956，The leading product has a brain and quiet injection、Huoxiang Zhengqi Water、Shaolin Zhengbone Essence、Brain Brain Spirit Film、Liuwei Dihuang Wan、Guanxin Suhe Wan, etc.。Where，The wake -up and static injection of the Tiandi Pharmaceutical Industry is a national medical insurance category B，The market share of brain drug market in the prescription of the hospital in the hospital ranks second，Due to its extensive indications and small adverse reactions, it has a huge market prospect。
At the same time with Tzuhiki, Tianjin Pharmaceutical's equity is also the Tianjin Unicom Marketing Planning Partnership (Limited Partnership) (Plapa & LDQUO; Jieli Marketing & RDQUO;)。18th，Tzursei、Unicom Marketing signed the "Share Transfer Agreement" with 6 natural person shareholders of Tiandi Pharmaceutical，Agreement agreement，Tzuhiki and Xieli Marketing have received 60%equity of Tiandi Pharmaceuticals held by 6 natural person shareholders。Where，Tzuoshi stake sports betting appstake betting appand cooperative marketing are transferred to 45%and 15%equity of Tiandi Pharmaceuticals，The price is 151 million yuan and 50.34 million yuan, respectively。After the equity is transferred，Tzuhisi will hold Tiandi Pharmaceutical。
The information is also displayed，Tiandi Pharmaceutical's existing houses have 38 places，Among them, 26 properties that have obtained the property right certificate in accordance with the law，12 real estate to the property right certificate，All are the self -invested construction of Tiandi Pharmaceutical，The ownership is clear; 1 existing state -owned land use rights; there is a machine and equipment that can be produced independently; 2 items of GMP certificate within the validity period。97 drug registration approval during the validity period。
As of April 30，Total Pharmaceutical's total assets are 116 million yuan，Net assets are 86.8477 million yuan。After evaluation of the income method，The entire equity of the shareholders of Tiandi Pharmaceutical is 364 million yuan，The value -added rate is 318.91%.
Current，Tzuhiki listed varieties and in research varieties，stroke、First Stake Sports Betting-aid My stake betting appmedication only one product for stirvation polyphenolic acid for injection。After the above acquisition is completed，Tzuoti will conduct basic research on the variety of Tiandi Pharmaceuticals，Continue to extract the effective ingredients of Chinese medicine、Separation、qualitative、Quantitative research，Develop a new preparation、New dosage research，Secondary development of the product; and use the existing rich product species and powerful marketing networks，Increase the development of domestic market。
Another，After the equity acquisition，Tiandi Pharmaceutical will be included in the scope of the merger statement，Can effectively expand sales scale，Increase the company's operating income，Enhance the company's profitability。January-April 2013，Tiandi Pharmaceutical owner's business income is 61.7202 million yuan，Net profit of 1011.79 million yuan。
September 24，Tzuoshi closed at 44.07 yuan，0.81%.
